Shuljia generic name orlistat capsules, generally does not cause cancer, the specific use of medication as prescribed by the doctor. Orlistat capsule can reduce the digestion and absorption of fat, applicable to adults aged 18 years and above with body mass index ≥ 24 overweight patients, should be combined with a low heat and low fat diet during the drug. The drug should be contraindicated in people who are allergic to the product, people who are not overweight, organ transplant recipients, people taking cyclosporine, people with cholestasis, people with malabsorption syndrome, and people with organic obesity (e.g. hypothyroidism). Common adverse reactions to the drug during use include increased gastrointestinal gas, urgency of stool, steatorrhea, fecal incontinence, fatty stools, oily spotting, and increased frequency of stools, but there is generally no risk of carcinogenicity. Specific dosing should be directed by a specialist.